Revvity RVTY
NYSE RVTY
$146.80 +1.07 (+0.73%)
As of: Sep 17, 2026 · 3:59 PM EDT

Revvity (RVTY) Income from Continuing Operations (2009 - 2026)

Revvity's (RVTY) quarterly Income from Continuing Operations came in at $53.5 million in Q3 2026, down 3.15% on a YoY basis from $55.2 million in Q3 2025, and up 30.78% quarter-over-quarter from $40.9 million in Q2 2026.

Analysis

Revvity (RVTY) Income from Continuing Operations (2009 - 2026) Analysis & Trends

Revvity (RVTY) has reported Income from Continuing Operations for 18 consecutive years, with $53.5 million the latest figure, recorded in Q3 2026.

  • For the quarter ending Q3 2026, Income from Continuing Operations fell 3.15% year-over-year to $53.5 million; the trailing twelve-month figure through Jul 2026 stood at $237.4 million (down 14.82% YoY), and the FY2025 full-year result was $239.9 million, down 15.26% from the prior year.
  • Income from Continuing Operations climbed to $53.5 million in Q3 2026 per RVTY's latest filing, from $40.9 million in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at $299.7 million in Q1 2022 and bottomed at $24.8 million in Q2 2023.
  • Historically, Income from Continuing Operations has averaged $91.4 million across 5 years, with a median of $64.1 million in 2022.
  • The sharpest annual moves came in 2023 and 2024: Income from Continuing Operations tumbled 86.5% in 2023, then jumped 187.62% in 2024.
  • Over 5 years, Income from Continuing Operations stood at $69.5 million in 2022, then plunged by 53.29% to $32.5 million in 2023, then soared by 172.21% to $88.4 million in 2024, then increased by 8.36% to $95.8 million in 2025, then tumbled by 44.16% to $53.5 million in 2026.
  • According to Business Quant data, Income from Continuing Operations over the past three periods registered $53.5 million, $40.9 million, and $95.8 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 1.76 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 870.00 Mn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 362.00 Mn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 207.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 53.48 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 54.62 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 371.40 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 5.01 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn -17.93 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -65.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 5, 2026 53.48 Mn
Apr 5, 2026 40.89 Mn
Dec 28, 2025 95.77 Mn
Sep 28, 2025 47.22 Mn
Jun 29, 2025 55.22 Mn
Mar 30, 2025 41.67 Mn
Dec 29, 2024 88.38 Mn
Sep 29, 2024 93.39 Mn
Jun 30, 2024 72.61 Mn
Mar 31, 2024 28.70 Mn
Oct 1, 2023 32.47 Mn
Jul 2, 2023 58.62 Mn
Apr 2, 2023 24.85 Mn
Jan 1, 2023 197.82 Mn
Oct 2, 2022 69.51 Mn
Jul 3, 2022 161.60 Mn
Apr 3, 2022 184.07 Mn
Jan 2, 2022 299.70 Mn
Oct 3, 2021 107.63 Mn
Jul 4, 2021 221.24 Mn